Skip to content

Analysis of the Effects of Using Different Loading Doses of Dexmedetomidine on the Treatment of Rigid Bronchoscopy under General Anesthesia

Analysis of the Effects of Using Different Loading Doses of Dexmedetomidine on the Treatment of Rigid Bronchoscopy under General Anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056626
Enrollment
Unknown
Registered
2022-02-09
Start date
2022-02-07
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of Dexmedetomidine

Interventions

Control group:Isodose normal saline
observation group D1:Dexmedetomidine0.5ug/kg
observation group D2:Dexmedetomidine0.75ug/kg

Sponsors

Xi'an Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The patient's clinical data is complete; 2. ASA is classified as Grade I to II; 3. No obvious abnormality of cardiovascular system; 4. Liver and kidney function and coagulation function are normal; 5. Have not taken drugs that affect the immune function of the body in the past month; 6. Be able to actively cooperate with medical staff to complete relevant examination and treatment; 7. Agree to sign relevant consent documents.

Exclusion criteria

Exclusion criteria: 1. The patient has a history of drug allergy; 2. The patient's blood coagulation function is abnormal or has oral anticoagulant drugs; 3. The patient is complicated with severe functional disorders such as heart, liver and kidney; 4. Patients with poor compliance; 5. Patients with psychosis; 6. Patients unable to cooperate with this study.

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure;heart rate;systolic blood pressure;sedation score;rate pressue produc;recovery time;consumption amount of anesthetic drugs;

Countries

China

Contacts

Public ContactDuan Chunyu

Xi'an Chest Hospital

duanchunyu90@126.com+86 13772117561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026